Skip to main content

Table 1 Cell cycle distribution of chondrosarcoma cell lines after 24 and 48 h exposure to different concentrations of diacereina

From: Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation

Cell line

Treatment

h

G0/G1 (%)

S (%)

G2/M (%)

Cal-78

control

24 h

57.48 ± 8.19

23.79 ± 5.84

18.73 ± 2.51

 

diacerein 30 μM

24 h

57.57 ± 8.30

25.23 ± 4.69

17.22 ± 3.68

 

diacerein 100 μM

24 h

62.04 ± 5.54

22.01 ± 2.64

15.94 ± 2.85

 

diacerein 300 μM

24 h

54.15 ± 7.33

26.76 ± 8.21

19.08 ± 3.67

 

control

48 h

61.08 ± 3.03

21.23 ± 2.31

17.68 ± 0.89

 

diacerein 30 μM

48 h

61.31 ± 1.16

23.66 ± 2.55

15.03 ± 1.80

 

diacerein 100 μM

48 h

69.42 ± 2.80*

17.79 ± 2.38

12.78 ± 3.92

 

diacerein 300 μM

48 h

56.95 ± 12.37

24.51 ± 9.02

18.53 ± 4.09

SW-1353

control

24 h

51.14 ± 7.05

22.73 ± 6.01

26.12 ± 1.35

 

diacerein 30 μM

24 h

49.05 ± 5.46

27.15 ± 6.08

23.79 ± 1.23

 

diacerein 100 μM

24 h

55.95 ± 4.11

19.53 ± 6.81

24.52 ± 6.83

 

diacerein 300 μM

24 h

45.32 ± 12.41

25.35 ± 8.41

29.33 ± 7.06

 

control

48 h

64.77 ± 7.67

15.65 ± 6.65

19.56 ± 1.03

 

diacerein 30 μM

48 h

65.54 ± 5.75

15.37 ± 5.80

19.08 ± 0.31

 

diacerein 100 μM

48 h

54.36 ± 5.92

22.16 ± 10.54

23.47 ± 4.86

 

diacerein 300 μM

48 h

44.38 ± 10.52*

25.73 ± 7.23

29.89 ± 5.33*

  1. aAsterisks represent significant differences between control and treated cells (p < 0.0.5; n = 3; mean ± S.D.)